Declan Murphy (@declangmurphy) 's Twitter Profile
Declan Murphy

@declangmurphy

Urologist & Director of GU Oncology, Peter MacCallum Cancer Centre | Professor, University of Melbourne | Podcasting at GU Cast. Views my own. RT = endorsement

ID: 272785838

linkhttp://www.declanmurphy.com.au calendar_today27-03-2011 05:21:14

7,7K Tweet

9,9K Takipçi

1,1K Takip Edilen

Michael Hofman (@drmhofman) 's Twitter Profile Photo

#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy ASCO #ASCO25 First prospective trial of Terbium-161 in any tumour type 🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq) 🟣 Very few side effects: 1 grade 3

#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy <a href="/ASCO/">ASCO</a> #ASCO25

First prospective trial of Terbium-161 in any tumour type
🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq)
🟣 Very few side effects: 1 grade 3
USANZ (@usanzurology) 's Twitter Profile Photo

Join us in Melbourne for #USANZ26! Convenor Renu Eapen and the organising committee invite you to the 2026 ASM at the Melbourne Convention & Exhibition Centre, 28 Feb – 3 Mar 2026. Discover what’s in store at asm.usanz.org.au

Join us in Melbourne for #USANZ26!

Convenor <a href="/RenuEapen/">Renu Eapen</a> and the organising committee invite you to the 2026 ASM at the Melbourne Convention &amp; Exhibition Centre, 28 Feb – 3 Mar 2026.

Discover what’s in store at asm.usanz.org.au
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

First-in-human results of terbium-161[161Tb]Tb-PSMA-I&T radioligand treatment in patients with metastatic castration-resistant prostate cancer (VIOLET) Presented at #ASCO25 meetings.asco.org/abstracts-pres… In this phase I/II trial, the novel radioligand therapy [¹⁶¹Tb]Tb-PSMA-I&T

First-in-human results of terbium-161[161Tb]Tb-PSMA-I&amp;T radioligand treatment in patients with metastatic castration-resistant prostate cancer (VIOLET) Presented at #ASCO25 

meetings.asco.org/abstracts-pres…

In this phase I/II trial, the novel radioligand therapy [¹⁶¹Tb]Tb-PSMA-I&amp;T
GU Cast | Urology podcast! (@gu_onc) 's Twitter Profile Photo

The ABC of mHSPC!! With Fred Saad and DrAndrewWeickhardt. A is for ARPI’s - who/when/which. B is for treatment Break. C is for Chemo - should anyone ever get it in the ARPI era?? Lots of banter Renu Eapen Declan Murphy youtu.be/corz2mBwR1c?si…

European Urology (@euplatinum) 's Twitter Profile Photo

European Urology remains at the top of our field in Nephrology and Urology! With the new IF of 25.2, over 2 million website downloads, and 40.7k followers on Twitter we are constantly striving to be a cut above the rest! Thank you to our Authors, Reviewers, and Readership!

European Urology remains at the top of our field in Nephrology and Urology!

With the new IF of 25.2, over 2 million website downloads, and 40.7k followers on Twitter we are constantly striving to be a cut above the rest!   

Thank you to our Authors, Reviewers, and Readership!
European Urology (@euplatinum) 's Twitter Profile Photo

Have you checked out the June Podcast? In the newest episode of the podcast Declan Murphy and Nikita Bhatt highlight two key papers from this month's journal, including interviews with key authors. They also catch up with Dr Eoin Dinneen (Melbourne, Australia), who gives a quick

Michael Hofman (@drmhofman) 's Twitter Profile Photo

New data from Denmark suggest improved survival with salvage radiotherapy in the PSMA PET/CT era. jnm.snmjournals.org/content/early/… SNMMI 📊The retrospective analysis excludes patients ineligible for RT based on PSMA PET/CT 💡Randomized data is ideal but challenging in 2025 with

New data from Denmark suggest improved survival with salvage radiotherapy in the PSMA PET/CT era.
jnm.snmjournals.org/content/early/… <a href="/SNM_MI/">SNMMI</a>

📊The retrospective analysis excludes patients ineligible for RT based on PSMA PET/CT
💡Randomized data is ideal but challenging in 2025 with
Declan Murphy (@declangmurphy) 's Twitter Profile Photo

Excellent short summary Ivo Schoots Anwar Padhani. MRI already funded and standard of care in Australia, UK etc, yet the vast majority of men in USA go straight to TRUS bx if PSA raised as MRI not uniformly funded. Can we change this? Matt Cooperberg Benjamin J. Davies MD Scott Eggener Dave Penson